Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
819,93 B | 23,56% | 6/6 | 34,75% | 16,00% | 37,51% | DOWN |
|
Johnson & Johnson NYSE:JNJ |
577,90 B | 5,27% | 5/5 | 6,91% | -31,55% | 2,11% | UP |
|
Merck NYSE:MRK |
295,13 B | 7,67% | 6/6 | -21,36% | -9,20% | 10,58% | UP |
|
Pfizer NYSE:PFE |
155,18 B | 7,82% | 4/6 | -5,31% | 21,23% | -1,03% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
120,03 B | 1,77% | 5/6 | -0,30% | -1,32% | 8,59% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
115,58 B | 13,44% | 6/6 | 6,43% | -5,59% | 22,65% | UP |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
76,91 B | 9,26% | 5/6 | 5,41% | 4,47% | 16,75% | UP |
|
Zoetis NYSE:ZTS |
49,27 B | 9,80% | 6/6 | 7,18% | 47,61% | 24,24% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
23,74 B | 15,13% | 5/6 | 2,36% | -36,02% | 12,17% | UP |
|
Viatris NasdaqGS:VTRS |
15,54 B | -3,69% | 4/6 | 2,81% | -41,84% | 25,93% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
10,60 B | 0,00% | 2/4 | 0,00% | 0,00% | 38,98% | UP |
|
Cytokinetics NasdaqGS:CYTK |
7,68 B | -1,08% | 1/6 | 4,92% | -36,26% | 44,25% | UP |
|
Balchem NasdaqGS:BCPC |
5,35 B | 8,75% | 6/6 | 8,46% | 4,34% | 21,29% | DOWN |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,60 B | 28,91% | 5/6 | 11,52% | -13,80% | 24,49% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
4,70 B | 63,45% | 3/5 | 33,54% | 93,36% | 44,56% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,08 B | 7,83% | 5/6 | 3,41% | -62,32% | 18,12% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
4,31 B | 10,36% | 5/6 | 124,19% | 17,29% | 48,26% | DOWN |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,88 B | 2,48% | 3/6 | 8,34% | -24,97% | 29,84% | UP |
|
Nektar Therapeutics NasdaqCM:NKTR |
2,07 B | 65,15% | 4/6 | 74,02% | -445,79% | 82,26% | UP |
